Personalized Cancer Medicine through Multiomics

AvMohammad Azhar Aziz,Snober Shabnam Mir

Häftad, Engelska, 2026

2 034 kr

Kommande

Beskrivning

Personalized Cancer Medicine through Multiomics explores the integration of multiomics to transform cancer diagnosis and treatment. The book delves into how the convergence of genomics, transcriptomics, proteomics, and metabolomics offers a comprehensive understanding of cancer biology, surpassing traditional single-omics approaches. Sections detail advancements in high-throughput technologies and computational methods, including machine learning, that enable the analysis of complex cancer datasets. Additional content discusses how multiomics identifies unique molecular signatures, novel therapeutic targets, and biomarkers, facilitating precise and individualized treatment strategies, particularly for a heterogeneous cancers.

For academics, this book serves as an essential resource, compiling fragmented research into a single, coherent volume. It provides foundational knowledge, the latest advancements, and practical applications of multiomics in personalized medicine. Researchers will benefit from interdisciplinary approaches, real-world examples, and cutting-edge methodologies, making it an invaluable reference for advancing their work in oncology.

Comprehensive coverage of genomics, transcriptomics, proteomics, metabolomics, and other omics to provide a holistic view of cancer mechanisms.
Detailed insights into high-throughput platforms, machine learning methods, and AI-driven analytics for complex cancer datasets.
Real-world case studies demonstrating successful applications of multiomics in achieving personalised cancer care.

Produktinformation

Utgivningsdatum:2026-12-01
Mått:152 x 229 x undefined mm
Vikt:450 g
Format:Häftad
Språk:Engelska
Antal sidor:440
Förlag:Elsevier Science
ISBN:9780443445484

Utforska kategorier

Farmakologi inom Medicin

Mer om författaren

Dr. Mohammad Azhar Aziz graduated from Jawaharlal Nehru University with PhD in Biotechnology. His work on colorectal cancer spanning more than two decades is rooted in strong interdisciplinary training. He was trained to work across disciplines through ‘Integrative Cancer Biology Program’ – An initiative by National Cancer Institute, NIH, USA to bring together diverse disciplines with a common goal to understand and defeat cancer. His expertise is in colorectal Cancer with pioneer work on precision and personalized medicine. He had been a recipient of several international awards. He established ‘Colorectal Cancer Biology Program’ at King Abdullah International Medical Research Center, KSA and recently 'Cancer Nanomedicine' Consortium at Aligarh Muslim University, India to bring together different departments for conducting cancer research and find translatable solutions for the patients.Dr. Snober S. Mir is working as Professor and Head, Department of Biosciences, Integral University, Lucknow. Her area of specialization is Molecular and Cell Biology, Cancer Biology and Yeast Biology. She has been a recipient of the Young Scientist Award by IACR during her doctoral studies and a research fellowship of Postgraduate Institute of Medical Education and Research (PGIMER). Dr. Mir worked as a Postdoctoral Fellow at the Medical College of Georgia, USA and as Senior Research Associate on a European Commission funded project at CSIR-CDRI, Lucknow. Her research work in cancer biology is funded by DBT, YSS-SERB, CRG-ANRF, ARG-ANRF and SERB-SURE grants. The research group also trains DAAD-RISE interns under the German Academic Exchange Service funded by DAAD-RISE Worldwide.

Innehållsförteckning

1. Introduction about omics2. Cancer Genomics3. Cancer Transcriptomics4. Cancer Proteomics5. Cancer Metabolomics6. Cancer lipidomics7. Cancer and other omics8. Cancer is a systems biology disease: Why multiomics is relevant for cancer?9. Tools and techniques for integration of data from multiomics10. Biomarker discovery through multiomics approach11. Identification of therapeutic targets by employing multiomics12. Multiomics for an individual patient: Relevance and possibilities13. Personalized medicine: Fact or Fiction/ Hope or Hype?14. Clinical translation of multiomics approach15. Ethical aspects of personalized medicine16. Economics of multiomics and personalized medicine